Legend Biotech Corporation (NASDAQ:LEGN) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Simply Wall StAug 1 14:52 ET

Will Genscript Cash Out of Legend Biotech in the Face of Fat Profit Temptation?

BenzingaAug 1 10:52 ET

Is Legend Biotech Corporation (LEGN) a Good Growth Stock to Buy?

Yahoo FinanceJul 29 15:24 ET

Genscript Biotech's US-Listed Unit Forecasts Up to $110 Million in January-June Loss

MT NewswiresJul 29 07:28 ET

Sector Update: Health Care Stocks Higher Late Afternoon

MT NewswiresJul 26 16:05 ET

Legend biotech (LEGN.US) is expected to have a net loss of up to 0.11 billion US dollars in the first half of the year after adjustment.

Legend biotech (LEGN.US) is expected to have a net loss of approximately $94.7 million to $0.1097 billion in the first half of 2024 after adjustments.

Zhitong FinanceJul 26 09:31 ET